Second Joint Sectoral Group (JSG) Meeting - Pharmaceutical Products – November 21, 2019

of the Protocol to the Comprehensive Economic and Trade Agreement (CETA) between the European Union and Canada on the Mutual Recognition of the Compliance and Enforcement Programs regarding Good Manufacturing Practices (GMP) for Pharmaceutical Products.

November 21, 2019 by Videoconference

Draft Agenda

1. Introduction and adoption of the agenda
2. Implementation of the CETA protocol for pharmaceuticals related administrative arrangements: state of play
3. Extension of the operational scope of the CETA protocol for pharmaceuticals to include active pharmaceutical ingredients (API)
4. CETA regulatory cooperation forum (RCF): extension of the scope of the CETA protocol for pharmaceuticals to recognize third countries drug facility inspections conducted by each party
5. Updates from Health Canada, the European Medicines Agency and the European Commission
6. Follow-up actions
7. Next meeting